Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Elad Moisseiev, Shimon Kurtz, Moshe Lazar & Gabi Shemesh. (2013) Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily. Clinical Ophthalmology 7, pages 1269-1273.
Read now
Read now
Jin-Wei Cheng, Shi-Wei Cheng, Dan-Yang Yu, Rui-Li Wei & Guo-Cai Lu. (2012) Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy. Current Medical Research and Opinion 28:4, pages 543-550.
Read now
Read now
Nurşen Yüksel, Mustafa Gök, Özgül Altıntaş & Yusuf Çağlar. (2011) Diurnal Intraocular Pressure Efficacy of the Timolol-Brimonidine Fixed Combination and the Timolol-Dorzolamide Fixed Combination as a First Choice Therapy in Patients with Pseudoexfoliation Glaucoma. Current Eye Research 36:9, pages 804-808.
Read now
Read now
Anton Hommer. (2011) Role of fixed combinations in the management of open-angle glaucoma. Expert Review of Pharmacoeconomics & Outcomes Research 11:1, pages 91-99.
Read now
Read now
Articles from other publishers (7)
Masaru Inatani, Yusuke Orii, Kentaro Iwasaki, Shogo Arimura, Hiromi Sunagawa, Minako Shiokawa, Kenji Inoue, Takuto Sakono, Takato Sakono, Rika Kuwamura, Akiko Yoshida, Junko Oi, Yasuaki Kuwayama, Kiyoshi Kano, Noriaki Kido, Akiko Matsuyama, Mineo Ozaki, Hideki Abe, Chizuru Inoue, Satoko Nakagawa, Kunihiro Musashi, Akiyasu Kanamori, Jinhee Lee, Shinichiro Otani, Ryota Aoki, Hirotaka Tanabe, Shunsuke Nakakura, Katsuyoshi Suzuki, Takeshi Sagara, Yoshiaki Saito, Motoyasu Sameshima, Mai Urahashi, Fumika Watanabe-Kitamura, Toshihiro Inoue, Fumie Kagaya, Yusuke Murai, Sotaro Mori, Kaori Ueda, Takuji Kurimoto, Yuko Yamada-Nakanishi, Makoto Nakamura, Takehiro Yamashita, Sosuke Ishiyama, Shinichi Manabe, Keiko Takaki, Ken Hayashi, Akiko Ishida, Aika Tsutsui, Kaoru Manabe & Masaki Tanito. (2023) Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study. Advances in Therapy 40:9, pages 4074-4092.
Crossref
Crossref
Jose J. Garcia-MedinaJavier Benitez-del-CastilloIñaki Rodríguez-AgirretxeFernando Lopez-LopezAntonio Moreno-ValladaresRafael Gimenez, Maria Parrilla Vallejo, Alfonso Anton lopez, Sergio Torregrosa & jorge loscos. (2022) Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain. Journal of Ocular Pharmacology and Therapeutics 38:3, pages 252-260.
Crossref
Crossref
Joon Mo Kim, Tae-Woo Kim, Chan Yun Kim, Hwang Ki Kim & Ki Ho Park. (2015) Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5 % timolol in normal-tension glaucoma patients. Japanese Journal of Ophthalmology 60:1, pages 20-26.
Crossref
Crossref
Göktuğ Seymenoğlu, Esin F. Baser, Bilge Öztürk & Ceren Gülhan. (2015) Comparison of Dorzolamide/Timolol Versus Brimonidine/Timolol Fixed Combination Therapy in the Management of Steroid-Induced Ocular Hypertension. Journal of Glaucoma 24:2, pages 111-116.
Crossref
Crossref
Patrick BudengeriJin-Wei ChengJi-Ping CaiRui-Li Wei. (2013) Efficacy and Tolerability of Fixed Combination of Brimonidine 0.2%/Timolol 0.5% Compared with Fixed Combination of Dorzolamide 2%/Timolol 0.5% in the Treatment of Patients with Elevated Intraocular Pressure: A Meta-Analysis of Randomized Controlled Trials. Journal of Ocular Pharmacology and Therapeutics 29:5, pages 474-479.
Crossref
Crossref
Gokhan Gulkilik, Ersin Oba & Mahmut Odabası. (2011) Comparison of fixed combinations of dorzolamide/timolol and brimonidine/timolol in patients with primary open-angle glaucoma. International Ophthalmology 31:6, pages 447-451.
Crossref
Crossref
Stella Arthur & Louis B. Cantor. (2011) Update on the role of alpha-agonists in glaucoma management. Experimental Eye Research 93:3, pages 271-283.
Crossref
Crossref